Thomas Milz - Net Worth and Insider Trading

Thomas Milz Net Worth

The estimated net worth of Thomas Milz is at least $0 dollars as of 2024-06-03. Thomas Milz is the Board of Directors of Apontis Pharma AG and owns about 0 shares of Apontis Pharma AG (XTER:APPH) stock worth over $0. Details can be seen in Thomas Milz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Milz has not made any transactions after 2024-05-13 and currently still holds the listed stock(s).

Transaction Summary of Thomas Milz

To

Thomas Milz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Milz owns 1 companies in total, including Apontis Pharma AG (XTER:APPH) .

Click here to see the complete history of Thomas Milz’s form 4 insider trades.

Insider Ownership Summary of Thomas Milz

Ticker Comapny Transaction Date Type of Owner
XTER:APPH Apontis Pharma AG 2024-05-13 Board of Directors

Thomas Milz Latest Holdings Summary

Thomas Milz currently owns a total of 1 stock. Thomas Milz owns 0 shares of Apontis Pharma AG (XTER:APPH) as of May 13, 2024, with a value of $0.

Latest Holdings of Thomas Milz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XTER:APPH Apontis Pharma AG 2024-05-13 0 8.52 0

Holding Weightings of Thomas Milz


Thomas Milz Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Milz has made a total of 2 transactions in Apontis Pharma AG (XTER:APPH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Apontis Pharma AG is the acquisition of 1,000 shares on May 13, 2024, which cost Thomas Milz around $8,960.

Insider Trading History of Thomas Milz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Milz Trading Performance

GuruFocus tracks the stock performance after each of Thomas Milz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Milz is -18.55%. GuruFocus also compares Thomas Milz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Milz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas Milz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas Milz

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 18.61 LIMIT LIMIT LIMIT LIMIT LIMIT

Thomas Milz Ownership Network

Ownership Network List of Thomas Milz

No Data

Ownership Network Relation of Thomas Milz

Insider Network Chart

Thomas Milz Owned Company Details

What does Apontis Pharma AG do?

Who are the key executives at Apontis Pharma AG?

Thomas Milz is the Board of Directors of Apontis Pharma AG. Other key executives at Apontis Pharma AG include Board of Directors Bruno Wohlschlegel , Chief Financial Officer Thomas Zimmermann , and Board of Directors Karlheinz Gast .

Apontis Pharma AG (XTER:APPH) Insider Trades Summary

Over the past 18 months, Thomas Milz made 2 insider transaction in Apontis Pharma AG (XTER:APPH) with a net purchase of 3,000. Other recent insider transactions involving Apontis Pharma AG (XTER:APPH) include a net purchase of 2,200 shares made by Thomas Zimmermann , a net purchase of 5,000 shares made by Karlheinz Gast , and a net purchase of 1,000 shares made by Bruno Wohlschlegel .

In summary, during the past 3 months, insiders sold 0 shares of Apontis Pharma AG (XTER:APPH) in total and bought 4,200 shares, with a net purchase of 4,200 shares. During the past 18 months, 0 shares of Apontis Pharma AG (XTER:APPH) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.

Apontis Pharma AG (XTER:APPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apontis Pharma AG Insider Transactions

No Available Data

Thomas Milz Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Milz. Currently GuruFocus does not have mailing address information for Thomas Milz.

Discussions on Thomas Milz

No discussions yet.